All In MedTech

FDA Clearance Tracker · K251877

JMS CAVEO A.V. Fistula Needle Set

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Aug 15, 2025 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Aug 15, 2025

Substantially Equivalent

Time to decision

58 days

Received Jun 18, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K251877
Device name
JMS CAVEO A.V. Fistula Needle Set
Applicant location
Hayward, CA
Received
Jun 18, 2025
Decided
Aug 15, 2025
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 876.5540

Every decision under product code FIE

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code FIE. The earliest in FDA's data is K770699, decided Jun 14, 1977.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for JMS North America Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.